The measurement and clinical relevance of brain atrophy in multiple sclerosis

[1]  Richard H. Price,et al.  Black holes , 2008, Scholarpedia.

[2]  Rohit Bakshi,et al.  Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis , 2006, Neurology.

[3]  M Filippi,et al.  Imaging the optic nerve in multiple sclerosis , 2005, Multiple sclerosis.

[4]  R. Bakshi,et al.  Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[5]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[6]  Rohit Bakshi,et al.  Regional lobar atrophy predicts memory impairment in multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.

[7]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[8]  Rohit Bakshi,et al.  The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction , 2005, NeuroImage.

[9]  Elizabeth Fisher,et al.  Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications , 2005, Multiple sclerosis.

[10]  D. Arnold,et al.  Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. , 2005, Archives of neurology.

[11]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[12]  E. Radue,et al.  Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a , 2005, Neurology.

[13]  Robert Zivadinov,et al.  Reproducibility and Accuracy of Quantitative Magnetic Resonance Imaging Techniques of Whole‐Brain Atrophy Measurement in Multiple Sclerosis , 2005, Journal of Neuroimaging.

[14]  Dr. Eduard Rindfleisch,et al.  Histologisches Detail zu der grauen Degeneration von Gehirn und Rückenmark. (Zugleich ein Beitrag zu der Lehre von der Entstehung und Verwandlung der Zelle.) , 1863, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[15]  H. Peitgen,et al.  Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis , 2004, Neuroradiology.

[16]  Marco Rovaris,et al.  Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[17]  Rohit Bakshi,et al.  Short-term brain atrophy changes in relapsing–remitting multiple sclerosis , 2004, Journal of the Neurological Sciences.

[18]  Rohit Bakshi,et al.  Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method , 2004, NeuroImage.

[19]  Xingchang Wei,et al.  Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed? , 2004, Multiple sclerosis.

[20]  A. Minagar,et al.  Pathogenesis of brain and spinal cord atrophy in multiple sclerosis. , 2004 .

[21]  Rohit Bakshi,et al.  Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[22]  R. Henry,et al.  Measurement of Whole‐Brain Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[23]  R. Rudick,et al.  Impact of Disease‐Modifying Therapies on Brain and Spinal Cord Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  Charles R G Guttmann,et al.  Magnetic Resonance Imaging Surrogates of Multiple Sclerosis Pathology and Their Relationship to Central Nervous System Atrophy , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[25]  Rohit Bakshi,et al.  Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[26]  C. Tench,et al.  Measurement of Spinal Cord Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[27]  R. Bakshi,et al.  Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. , 2004, AJNR. American journal of neuroradiology.

[28]  Alan J. Thompson,et al.  Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.

[29]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[30]  M Rovaris,et al.  Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.

[31]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[32]  Massimo Filippi,et al.  Indirect evidence for early widespread gray matter involvement in relapsing–remitting multiple sclerosis , 2004, NeuroImage.

[33]  C. Pozzilli,et al.  The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis , 2004, Journal of Neurology.

[34]  P. Calabresi,et al.  Interferon-&bgr;-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb− and NAb+ patients , 2004, Neurology.

[35]  R. Grossman,et al.  Neuronal cell injury precedes brain atrophy in multiple sclerosis , 2004, Neurology.

[36]  N. Lobaugh,et al.  Structural brain abnormalities in multiple sclerosis patients with major depression , 2004, Neurology.

[37]  Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy , 2004, Journal of Clinical Neuroscience.

[38]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[39]  A J Thompson,et al.  Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.

[40]  Rohit Bakshi,et al.  Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. , 2004, Frontiers in bioscience : a journal and virtual library.

[41]  P. Rieckmann,et al.  Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS) , 2004, Journal of Neurology.

[42]  M. A. Horsfield,et al.  Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences , 2003, Journal of the Neurological Sciences.

[43]  L. Blumhardt,et al.  The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three‐dimensional MRI study , 2003, Acta neurologica Scandinavica.

[44]  A J Thompson,et al.  The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study , 2003, Journal of neurology, neurosurgery, and psychiatry.

[45]  A. Thompson,et al.  Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.

[46]  Rohit Bakshi,et al.  Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[47]  J. M. Pumar,et al.  Atrofia cerebral en pacientes con esclerosis múltiple tratados con bolos periódicos de metilprednisolona , 2003 .

[48]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[49]  C. Tench,et al.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon β-1a (Rebif) treatment trial , 2003, Journal of neurology, neurosurgery, and psychiatry.

[50]  S. Nelson,et al.  MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[51]  Zhengrong Liang,et al.  Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients , 2003, Neurology.

[52]  Rohit Bakshi,et al.  A semiautomated measure of whole-brain atrophy in multiple sclerosis , 2003, Journal of the Neurological Sciences.

[53]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[54]  Rohit Bakshi,et al.  Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study , 2003, Neuroreport.

[55]  Jan Kassubek,et al.  Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study , 2003, Neuroreport.

[56]  N. Roberts,et al.  C erebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years , 2003, Multiple sclerosis.

[57]  Bruno Alfano,et al.  Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load , 2003, NeuroImage.

[58]  O. Khan,et al.  Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis , 2003, Neurology.

[59]  D. Miller,et al.  Interferon β-1a in primary progressive MS , 2003, Neurology.

[60]  J H Simon,et al.  Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.

[61]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[62]  R. Zivadinov,et al.  Is Gadolinium Enhancement Predictive of the Development of Brain Atrophy in Multiple Sclerosis? A Review of the Literature , 2002, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[63]  C H Polman,et al.  Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone , 2002, Multiple sclerosis.

[64]  F. Barkhof,et al.  Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.

[65]  B. Lewis,et al.  Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFN&bgr;-1b , 2002, Neurology.

[66]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[67]  R. Zivadinov,et al.  Depressive symptoms and MRI changes in multiple sclerosis , 2002, European journal of neurology.

[68]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[69]  Giuseppe Iannucci,et al.  MR correlates of cerebral atrophy in patients with multiple sclerosis , 2002, Journal of Neurology.

[70]  C. Pozzilli,et al.  MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a , 2002, Multiple sclerosis.

[71]  G. Scotti,et al.  Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis , 2002, NeuroImage.

[72]  Alan J Thompson,et al.  The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology , 2002, Journal of magnetic resonance imaging : JMRI.

[73]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[74]  Rohit Bakshi,et al.  Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. , 2002, Archives of neurology.

[75]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[76]  R. Rudick,et al.  Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.

[77]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[78]  M Rovaris,et al.  Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. , 2001, Brain : a journal of neurology.

[79]  L G Nyúl,et al.  Relapsing-remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter , 2000 .

[80]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[81]  Johan Montagnat,et al.  Automated Estimation of Brain Volume in Multiple Sclerosis with BICCR , 2001, IPMI.

[82]  C. Lucchinetti,et al.  A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.

[83]  G Cazzato,et al.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[84]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[85]  R Bakshi,et al.  Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[86]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[87]  Ponnada A Narayana,et al.  United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates , 2001 .

[88]  J S Wolinsky,et al.  United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center. , 2001, Multiple sclerosis.

[89]  M Rovaris,et al.  Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis , 2001, Multiple sclerosis.

[90]  J. Simon.  Brain and Spinal Cord Atrophy in Multiple Sclerosis , 2000, CNS drugs.

[91]  C R Guttmann,et al.  A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. , 2001, Archives of neurology.

[92]  M. Gobbini,et al.  Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. , 2001, Archives of neurology.

[93]  M Rovaris,et al.  Whole brain volume changes in patients with progressive MS treated with cladribine , 2000, Neurology.

[94]  Bruno Alfano,et al.  Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis , 2000 .

[95]  J. Duda,et al.  Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a , 2000, Multiple sclerosis.

[96]  G J Barker,et al.  The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.

[97]  S J Nelson,et al.  A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis , 2000, Multiple sclerosis.

[98]  R. Bakshi,et al.  Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. , 2000, Archives of neurology.

[99]  G Becker,et al.  The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. , 2000, Archives of neurology.

[100]  L D Blumhardt,et al.  Short‐term ventricular volume changes on serial MRI in multiple sclerosis , 2000, Acta neurologica Scandinavica.

[101]  J. Udupa,et al.  The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS , 2000, Neurology.

[102]  A. Thompson,et al.  One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[103]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[104]  M Rovaris,et al.  MRI correlates of cognitive dysfunction in multiple sclerosis patients. , 2000, Journal of neurovirology.

[105]  V. Janardhan,et al.  Brain MRI lesions and atrophy are related to depression in multiple sclerosis , 2000, Neuroreport.

[106]  Nick C Fox,et al.  Detection of ventricular enlargement in patients at the earliest clinical stage of MS , 2000, Neurology.

[107]  J. Mugler,et al.  White matter abnormalities in mobility-impaired older persons , 2000, Neurology.

[108]  Caterina Mainero,et al.  Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability , 2000, Journal of the Neurological Sciences.

[109]  R. Kinkel,et al.  A Wallerian degeneration pattern in patients at risk for MS , 2000, Neurology.

[110]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[111]  M N Rossor,et al.  Progressive cerebral atrophy in MS , 2000, Neurology.

[112]  J K Udupa,et al.  Glatiramer acetate (Copaxone) treatment in relapsing–remitting MS , 2000, Neurology.

[113]  M. Rovaris,et al.  Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study , 1999, Journal of the Neurological Sciences.

[114]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.

[115]  J. DeLuca,et al.  Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation , 1999, Journal of neurology, neurosurgery, and psychiatry.

[116]  G. Barker,et al.  Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H , 1999, Neurology.

[117]  Frederik Barkhof,et al.  MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) , 1999, Multiple sclerosis.

[118]  R. Herndon,et al.  A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.

[119]  P. Dastidar,et al.  Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis , 1999, Journal of the Neurological Sciences.

[120]  G. Ebers,et al.  Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.

[121]  W R Kinkel,et al.  High‐Resolution Fluorodeoxyglucose Positron Emission Tomography Shows Both Global and Regional Cerebral Hypometabolism in Multiple Sclerosis , 1998, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[122]  O. Stuve,et al.  Interferon beta in the treatment of multiple sclerosis , 1998, Neurology.

[123]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[124]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[125]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[126]  R Kikinis,et al.  Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.

[127]  J. Ruutiainen,et al.  The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. , 1997, Brain : a journal of neurology.

[128]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[129]  Supun Samarasekera,et al.  Detection and quantification of MS lesions using fuzzy topological principles , 1996, Medical Imaging.

[130]  L. Amaducci,et al.  Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. , 1995, Archives of neurology.

[131]  Dewey Odhner,et al.  3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system , 1994, Medical Imaging.

[132]  A. Kaasik,et al.  [The prognosis of multiple sclerosis: computed tomographic comparisons]. , 1993, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[133]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[134]  R. McGhee,et al.  Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[135]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[136]  P. A. Beatty,et al.  Cognitive disturbances in patients with relapsing remitting multiple sclerosis. , 1989, Archives of neurology.

[137]  I Litvan,et al.  Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. , 1988, Archives of neurology.

[138]  J H Simon,et al.  Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. , 1987, AJNR. American journal of neuroradiology.

[139]  T. Hammeke,et al.  Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. , 1985, Archives of neurology.

[140]  I Grant,et al.  Deficient learning and memory in early and middle phases of multiple sclerosis. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[141]  Neil Gordon,et al.  Apparent Cerebral Atrophy in Patients on Treatment with Steroids , 1980, Developmental medicine and child neurology.

[142]  R. Carswell.  XX. Pathological Anatomy. Illustrations of the Elementary Forms of Disease. , 1833 .